1. Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process. (2nd April 2019) Authors: McGee, Jacob; Peart, Teresa M.; Foley, Norine; Bertrand, Monique; Prefontaine, Michel; Sugimoto, Akira; Ettler, Helen; Welch, Stephen; Panabaker, Karen Other Names: Kanat Ozkan Academic Editor. Journal: Journal of oncology Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?. Issue 3 (1st March 2016) Authors: Velker, Vikram; D'Souza, David; Prefontaine, Michel; McGee, Jacob; Leung, Eric Journal: International journal of gynecological cancer Issue: Volume 26:Issue 3(2016) Page Start: 491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?. Issue 3 (March 2016) Authors: Velker, Vikram; D'Souza, David; Prefontaine, Michel; McGee, Jacob; Leung, Eric Journal: International journal of gynecological cancer Issue: Volume 26:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗